130 related articles for article (PubMed ID: 3514758)
1. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
Morgan BP; Imagawa DK; Dankert JR; Ramm LE
J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
[TBL] [Abstract][Full Text] [Related]
2. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
Kim SH; Carney DF; Hammer CH; Shin ML
J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
5. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
6. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites.
MacKay SL; Dankert JR
J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122
[TBL] [Abstract][Full Text] [Related]
7. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
[TBL] [Abstract][Full Text] [Related]
8. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
9. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors.
Davé SJ; Sodetz JM
J Immunol; 1990 Apr; 144(8):3087-90. PubMed ID: 2324496
[TBL] [Abstract][Full Text] [Related]
11. Membrane vesiculation protects erythrocytes from destruction by complement.
Iida K; Whitlow MB; Nussenzweig V
J Immunol; 1991 Oct; 147(8):2638-42. PubMed ID: 1918984
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
[TBL] [Abstract][Full Text] [Related]
13. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
Ramm LE; Whitlow MB; Mayer MM
J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
[TBL] [Abstract][Full Text] [Related]
14. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
Tschopp J; Masson D; Stanley KK
Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
16. The modifications of the final stages of the complement reaction by alkali metal cations.
Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
[TBL] [Abstract][Full Text] [Related]
17. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of the complement-regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with IL-1 beta, endotoxin, IFN-gamma, or phorbol ester.
Schieren G; Janssen O; Hänsch GM
J Immunol; 1992 May; 148(10):3183-8. PubMed ID: 1578143
[TBL] [Abstract][Full Text] [Related]
19. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
[TBL] [Abstract][Full Text] [Related]
20. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
Schönermark S; Filsinger S; Berger B; Hänsch GM
Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
